Farms.com Home   News

NCBA Urges Vilsack to Halt Brazilian Beef Imports

Today, the National Cattlemen's Beef Association (NCBA) called on Secretary Vilsack to immediately suspend all imports of fresh beef from Brazil to the United States.

In the letter to USDA, NCBA asked for a suspension until the agency conducts a thorough risk assessment and review of the processes that Brazil's Ministry of Agriculture, Livestock, and Food Supply (MAPA) uses to detect disease and other threats to consumers. NCBA also urged USDA to review Brazil's veterinary diagnostic laboratory system.

"It's time to keep Brazilian fresh beef out of this country until USDA can confirm that Brazil meets the same consumer and food safety standards that we apply to all our trade partners," said NCBA Vice President of Government Affairs Ethan Lane.

"NCBA has long expressed concerns about Brazil's history of failing to report atypical BSE cases in a timely manner, a pattern that stretches back as far as 2012. Their poor track record and lack of transparency raises serious doubts about Brazil's ability to produce cattle and beef at an equivalent level of safety as American producers. If they cannot meet that bar, their product has no place here," added Lane.

According to reports published by the World Organization for Animal Health (OIE), Brazil took more than eight weeks to report two confirmed cases of atypical bovine spongiform encephalopathy (BSE). The OIE requires countries to report within 24 hours for any animal disease event that could be of international concern for public health emergencies.

After the market devastation of 2003, American cattle producers have worked diligently to protect consumers and restore confidence both at home and abroad. Farmers and ranchers benefit greatly from the demand for beef that is built upon a commitment to integrity, transparency, and the highest scientific standards.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.